Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spheroids, Cellular | 5 | 2023 | 351 | 0.540 |
Why?
|
Receptor, erbB-2 | 2 | 2020 | 2416 | 0.370 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2023 | 5221 | 0.310 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13102 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2018 | 578 | 0.250 |
Why?
|
Cell Line, Tumor | 20 | 2023 | 16689 | 0.230 |
Why?
|
Carbonic Anhydrases | 1 | 2024 | 115 | 0.230 |
Why?
|
Myeloid Progenitor Cells | 1 | 2023 | 111 | 0.230 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3557 | 0.230 |
Why?
|
Mutation | 10 | 2023 | 29786 | 0.220 |
Why?
|
Immunity | 2 | 2019 | 1012 | 0.220 |
Why?
|
Quinolines | 2 | 2020 | 732 | 0.220 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2023 | 5172 | 0.200 |
Why?
|
Immunotherapy | 3 | 2023 | 4445 | 0.190 |
Why?
|
Receptor, erbB-3 | 1 | 2021 | 142 | 0.190 |
Why?
|
Immune Evasion | 1 | 2023 | 360 | 0.170 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11524 | 0.170 |
Why?
|
Myeloid Cells | 1 | 2023 | 810 | 0.170 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2019 | 185 | 0.160 |
Why?
|
Immunophenotyping | 3 | 2019 | 1880 | 0.160 |
Why?
|
Antineoplastic Agents | 7 | 2021 | 13695 | 0.150 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2023 | 1692 | 0.150 |
Why?
|
Membrane Proteins | 4 | 2022 | 7880 | 0.150 |
Why?
|
Cell Culture Techniques | 3 | 2021 | 1678 | 0.150 |
Why?
|
Mice | 25 | 2024 | 81183 | 0.140 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1276 | 0.130 |
Why?
|
Telomere | 2 | 2012 | 910 | 0.130 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1878 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 322 | 0.130 |
Why?
|
Pyrrolidinones | 1 | 2015 | 117 | 0.130 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6314 | 0.120 |
Why?
|
Mice, SCID | 1 | 2020 | 2716 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 538 | 0.120 |
Why?
|
Immunoconjugates | 1 | 2021 | 901 | 0.120 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2018 | 428 | 0.120 |
Why?
|
Gene Amplification | 1 | 2018 | 1063 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 546 | 0.120 |
Why?
|
Anilides | 1 | 2016 | 408 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1270 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2133 | 0.110 |
Why?
|
Huntington Disease | 3 | 2005 | 1124 | 0.110 |
Why?
|
Signal Transduction | 8 | 2019 | 23403 | 0.110 |
Why?
|
Ovarian Neoplasms | 2 | 2021 | 4838 | 0.110 |
Why?
|
Exons | 1 | 2018 | 2437 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 484 | 0.100 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2012 | 38 | 0.100 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 607 | 0.100 |
Why?
|
Animals | 25 | 2024 | 168757 | 0.100 |
Why?
|
Chromosome Breakage | 1 | 2012 | 173 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2849 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2018 | 8428 | 0.100 |
Why?
|
Mitochondria | 3 | 2011 | 3520 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 489 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2751 | 0.090 |
Why?
|
Sunlight | 1 | 2012 | 325 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.090 |
Why?
|
Mesothelioma | 1 | 2016 | 818 | 0.090 |
Why?
|
Telomerase | 2 | 2012 | 730 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2013 | 9648 | 0.090 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2016 | 1821 | 0.090 |
Why?
|
Cell Proliferation | 4 | 2020 | 10481 | 0.080 |
Why?
|
Apoptosis | 3 | 2021 | 9727 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2024 | 3143 | 0.080 |
Why?
|
Aneuploidy | 1 | 2012 | 530 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3703 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 6 | 2023 | 5535 | 0.080 |
Why?
|
p21-Activated Kinases | 1 | 2008 | 128 | 0.080 |
Why?
|
Nuclear Proteins | 3 | 2007 | 5853 | 0.070 |
Why?
|
Melanoma | 2 | 2018 | 5510 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2024 | 4262 | 0.070 |
Why?
|
rho GTP-Binding Proteins | 1 | 2008 | 293 | 0.070 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 328 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1338 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5524 | 0.070 |
Why?
|
Mitosis | 1 | 2012 | 1208 | 0.070 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 166 | 0.070 |
Why?
|
Chromosomal Instability | 1 | 2007 | 184 | 0.070 |
Why?
|
Chromosome Aberrations | 3 | 2007 | 1813 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2010 | 721 | 0.070 |
Why?
|
DNA Repeat Expansion | 1 | 2005 | 66 | 0.070 |
Why?
|
Polyploidy | 1 | 2005 | 114 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 692 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 4479 | 0.060 |
Why?
|
Pyridines | 1 | 2016 | 2825 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2007 | 299 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2024 | 10180 | 0.060 |
Why?
|
Humans | 34 | 2024 | 744343 | 0.060 |
Why?
|
NF-kappa B | 1 | 2013 | 2499 | 0.060 |
Why?
|
Cytokinesis | 1 | 2005 | 177 | 0.060 |
Why?
|
Neoplasms | 4 | 2019 | 21683 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2007 | 1202 | 0.060 |
Why?
|
Plasma Cells | 1 | 2007 | 591 | 0.060 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2023 | 41 | 0.060 |
Why?
|
Lysosomes | 2 | 2023 | 893 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2012 | 2942 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2007 | 4462 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2012 | 2948 | 0.060 |
Why?
|
Genes, p53 | 1 | 2005 | 755 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 109 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2734 | 0.050 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2019 | 1038 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18029 | 0.050 |
Why?
|
Multiple Myeloma | 2 | 2013 | 5181 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 182 | 0.050 |
Why?
|
Protein Kinases | 1 | 2009 | 1640 | 0.050 |
Why?
|
Sirolimus | 1 | 2009 | 1564 | 0.050 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2005 | 895 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 244 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2017 | 4851 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2010 | 11483 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4034 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 1903 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2007 | 1144 | 0.050 |
Why?
|
Calcium Signaling | 1 | 2005 | 721 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6364 | 0.050 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9734 | 0.040 |
Why?
|
Caspases | 1 | 2023 | 928 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2916 | 0.040 |
Why?
|
Phthalazines | 1 | 2021 | 363 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2003 | 1472 | 0.040 |
Why?
|
Genome, Human | 1 | 2012 | 4420 | 0.040 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2021 | 434 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1730 | 0.040 |
Why?
|
Energy Metabolism | 2 | 2007 | 2899 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 49 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2023 | 2109 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3920 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 9438 | 0.040 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2018 | 123 | 0.040 |
Why?
|
Transcription Factors | 4 | 2011 | 12208 | 0.040 |
Why?
|
Peptides | 2 | 2007 | 4409 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2008 | 1634 | 0.040 |
Why?
|
Quinoxalines | 1 | 2019 | 290 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2018 | 320 | 0.040 |
Why?
|
Mice, Nude | 3 | 2009 | 3689 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 1941 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3567 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2016 | 63 | 0.040 |
Why?
|
Organoids | 1 | 2023 | 701 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 195 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2013 | 1655 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1434 | 0.030 |
Why?
|
Apyrase | 1 | 2018 | 364 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 1988 | 0.030 |
Why?
|
Antibodies | 1 | 2024 | 2460 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6895 | 0.030 |
Why?
|
Drug Synergism | 1 | 2019 | 1792 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3401 | 0.030 |
Why?
|
Glioblastoma | 1 | 2010 | 3481 | 0.030 |
Why?
|
Ascites | 1 | 2016 | 344 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2016 | 338 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3206 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 286 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2016 | 2727 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2938 | 0.030 |
Why?
|
Female | 9 | 2020 | 380194 | 0.030 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2013 | 197 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2012 | 98 | 0.030 |
Why?
|
Comet Assay | 1 | 2012 | 71 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2649 | 0.030 |
Why?
|
Adenosine Triphosphate | 2 | 2011 | 2025 | 0.030 |
Why?
|
DNA Fragmentation | 1 | 2012 | 242 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2010 | 3616 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1838 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 4554 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5256 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 828 | 0.020 |
Why?
|
Acrylamides | 1 | 2012 | 255 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2012 | 791 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2012 | 235 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2019 | 2540 | 0.020 |
Why?
|
Gluconeogenesis | 1 | 2011 | 183 | 0.020 |
Why?
|
Cells, Cultured | 4 | 2007 | 19229 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2017 | 11366 | 0.020 |
Why?
|
Cell Survival | 2 | 2013 | 5882 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6386 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2010 | 464 | 0.020 |
Why?
|
Pyrazoles | 1 | 2019 | 1972 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11124 | 0.020 |
Why?
|
Genome | 2 | 2007 | 1808 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 8863 | 0.020 |
Why?
|
Melanocytes | 1 | 2012 | 515 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2013 | 1401 | 0.020 |
Why?
|
Mutagenesis | 1 | 2012 | 1266 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6773 | 0.020 |
Why?
|
Dromaiidae | 1 | 2007 | 7 | 0.020 |
Why?
|
Genomic Instability | 1 | 2012 | 695 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2008 | 2503 | 0.020 |
Why?
|
Synteny | 1 | 2007 | 79 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 898 | 0.020 |
Why?
|
Hypergammaglobulinemia | 1 | 2007 | 74 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2012 | 1060 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3586 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5974 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 300 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9583 | 0.020 |
Why?
|
Oncogenes | 1 | 2012 | 1265 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1375 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 21827 | 0.020 |
Why?
|
Quinazolines | 1 | 2012 | 1356 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6538 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 376 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2011 | 817 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 3002 | 0.020 |
Why?
|
Myoepithelioma | 1 | 2005 | 43 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4568 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1526 | 0.020 |
Why?
|
DNA Replication | 1 | 2012 | 1399 | 0.020 |
Why?
|
Cell Cycle | 1 | 2013 | 2967 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2005 | 425 | 0.020 |
Why?
|
Doxorubicin | 1 | 2011 | 2234 | 0.020 |
Why?
|
Mammary Glands, Animal | 1 | 2005 | 276 | 0.010 |
Why?
|
Chromones | 1 | 2003 | 154 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2005 | 477 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4186 | 0.010 |
Why?
|
Alleles | 2 | 2005 | 6933 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2077 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3144 | 0.010 |
Why?
|
Bone Diseases | 1 | 2007 | 416 | 0.010 |
Why?
|
Phosphorylation | 2 | 2005 | 8436 | 0.010 |
Why?
|
Matrix Metalloproteinases | 1 | 2005 | 391 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 829 | 0.010 |
Why?
|
Metabolic Networks and Pathways | 1 | 2007 | 783 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7322 | 0.010 |
Why?
|
RNA Splicing | 1 | 2007 | 907 | 0.010 |
Why?
|
DNA Damage | 1 | 2012 | 2432 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2003 | 463 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2003 | 430 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2007 | 1142 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 2007 | 7722 | 0.010 |
Why?
|
RNA | 1 | 2011 | 2749 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 491 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 514 | 0.010 |
Why?
|
Pyrimidines | 1 | 2012 | 2942 | 0.010 |
Why?
|
Morpholines | 1 | 2003 | 571 | 0.010 |
Why?
|
Cytosol | 1 | 2003 | 901 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2007 | 2715 | 0.010 |
Why?
|
Immunoblotting | 1 | 2003 | 1682 | 0.010 |
Why?
|
Aging | 2 | 2011 | 8664 | 0.010 |
Why?
|
Serine | 1 | 2003 | 826 | 0.010 |
Why?
|
Aged | 3 | 2017 | 163280 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2915 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2529 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2011 | 1912 | 0.010 |
Why?
|
Phenotype | 2 | 2008 | 16365 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29063 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9239 | 0.010 |
Why?
|
Age of Onset | 1 | 2005 | 3271 | 0.010 |
Why?
|
Skin Diseases | 1 | 2007 | 1065 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3386 | 0.010 |
Why?
|
beta Catenin | 1 | 2003 | 1059 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2009 | 2752 | 0.010 |
Why?
|
Middle Aged | 3 | 2017 | 213383 | 0.010 |
Why?
|
Adult | 3 | 2017 | 214055 | 0.010 |
Why?
|
Myocardium | 1 | 2011 | 4776 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 1364 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3701 | 0.010 |
Why?
|
Models, Genetic | 1 | 2007 | 3494 | 0.010 |
Why?
|
Corpus Striatum | 1 | 2003 | 1221 | 0.010 |
Why?
|
Cell Movement | 1 | 2008 | 5217 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4803 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2007 | 2149 | 0.010 |
Why?
|
Male | 4 | 2017 | 350118 | 0.010 |
Why?
|
Liver | 1 | 2011 | 7474 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4328 | 0.010 |
Why?
|
Cell Membrane | 1 | 2003 | 3748 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4665 | 0.010 |
Why?
|
Trans-Activators | 1 | 2003 | 2924 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3690 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63114 | 0.010 |
Why?
|
Genomics | 1 | 2008 | 5720 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 57776 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 12072 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 9338 | 0.000 |
Why?
|
Brain | 1 | 2003 | 26385 | 0.000 |
Why?
|